- Home
- CPAC vs DCTH Comparison
CPAC vs DCTH Comparison
Compare CPAC & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPAC
- DCTH
- Stock Information
- Founded
- CPAC 1949
- DCTH 1988
- Country
- CPAC Peru
- DCTH United States
- Employees
- CPAC N/A
- DCTH N/A
- Industry
- CPAC Building Materials
- DCTH Medical/Dental Instruments
- Sector
- CPAC Industrials
- DCTH Health Care
- Exchange
- CPAC Nasdaq
- DCTH Nasdaq
- Market Cap
- CPAC 436.7M
- DCTH 518.0M
- IPO Year
- CPAC 2012
- DCTH N/A
- Fundamental
- Price
- CPAC $5.50
- DCTH $12.11
- Analyst Decision
- CPAC Sell
- DCTH Strong Buy
- Analyst Count
- CPAC 1
- DCTH 4
- Target Price
- CPAC $6.00
- DCTH $22.75
- AVG Volume (30 Days)
- CPAC 7.0K
- DCTH 452.3K
- Earning Date
- CPAC 05-02-2025
- DCTH 05-13-2025
- Dividend Yield
- CPAC 9.20%
- DCTH N/A
- EPS Growth
- CPAC 17.75
- DCTH N/A
- EPS
- CPAC 0.12
- DCTH N/A
- Revenue
- CPAC $524,464,683.00
- DCTH $37,205,000.00
- Revenue This Year
- CPAC N/A
- DCTH $128.78
- Revenue Next Year
- CPAC N/A
- DCTH $54.07
- P/E Ratio
- CPAC $9.25
- DCTH N/A
- Revenue Growth
- CPAC 1.44
- DCTH 1701.69
- 52 Week Low
- CPAC $5.10
- DCTH $5.12
- 52 Week High
- CPAC $6.65
- DCTH $16.97
- Technical
- Relative Strength Index (RSI)
- CPAC 47.88
- DCTH 49.94
- Support Level
- CPAC $5.40
- DCTH $11.74
- Resistance Level
- CPAC $5.60
- DCTH $13.09
- Average True Range (ATR)
- CPAC 0.23
- DCTH 0.83
- MACD
- CPAC 0.01
- DCTH 0.17
- Stochastic Oscillator
- CPAC 60.61
- DCTH 70.39
About CPAC Cementos Pacasmayo S.A.A. (Each representing five)
Cementos Pacasmayo SAA is a Peruvian cement company that primarily produces, distributes, and sells cement and cement-related materials, such as concrete blocks and ready-mix concrete. The company's products are primarily used in construction. It also produces and sells quicklime for use in mining operations. The company sells its products mainly in the northern part of Peru. It owns three cement production facilities. Its flagship Pacasmayo facility is located in the northwest region of Peru, while its new cement plant in Piura and smaller Rioja facility are located in the northeast region of Peru.
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.